Your browser doesn't support javascript.
loading
Successful BRAF/MEK inhibition in a patient with BRAFV600E-mutated extrapancreatic acinar cell carcinoma.
Busch, Elena; Kreutzfeldt, Simon; Agaimy, Abbas; Mechtersheimer, Gunhild; Horak, Peter; Brors, Benedikt; Hutter, Barbara; Fröhlich, Martina; Uhrig, Sebastian; Mayer, Philipp; Schröck, Evelin; Stenzinger, Albrecht; Glimm, Hanno; Jäger, Dirk; Springfeld, Christoph; Fröhling, Stefan; Zschäbitz, Stefanie.
Affiliation
  • Busch E; Department of Medical Oncology, University Hospital Heidelberg, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, 69120, Germany.
  • Kreutzfeldt S; Department of Translational Medical Oncology, NCT Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • Agaimy A; Institute of Pathology, University Hospital Erlangen, Erlangen, 91054, Germany.
  • Mechtersheimer G; Institute of Pathology, University Hospital Heidelberg, Heidelberg, 69120, Germany.
  • Horak P; Department of Translational Medical Oncology, NCT Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • Brors B; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, Heidelberg, 69120, Germany.
  • Hutter B; German Cancer Consortium.
  • Fröhlich M; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, Heidelberg, 69120, Germany.
  • Uhrig S; Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, 69120, Germany.
  • Mayer P; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, Heidelberg, 69120, Germany.
  • Schröck E; Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, 69120, Germany.
  • Stenzinger A; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, Heidelberg, 69120, Germany.
  • Glimm H; Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, 69120, Germany.
  • Jäger D; Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, 69120, Germany.
  • Springfeld C; NCT Partner Site Dresden, University Cancer Center (UCC) Dresden, Dresden, 01307, Germany.
  • Fröhling S; Institute of Clinical Genetics, Technical University of Dresden, Dresden, 01307, Germany.
  • Zschäbitz S; Institute of Pathology, University Hospital Heidelberg, Heidelberg, 69120, Germany.
Cold Spring Harb Mol Case Stud ; 6(4)2020 08.
Article de En | MEDLINE | ID: mdl-32843432
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome à cellules acineuses / Protéines proto-oncogènes B-raf / MAP Kinase Kinase 1 Type d'étude: Prognostic_studies Limites: Adult / Humans / Male Langue: En Journal: Cold Spring Harb Mol Case Stud Année: 2020 Type de document: Article Pays d'affiliation: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome à cellules acineuses / Protéines proto-oncogènes B-raf / MAP Kinase Kinase 1 Type d'étude: Prognostic_studies Limites: Adult / Humans / Male Langue: En Journal: Cold Spring Harb Mol Case Stud Année: 2020 Type de document: Article Pays d'affiliation: Allemagne